PainReform Ltd. - stock earnings
PRFX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -4.9 million USD | ? USD |
2023Q3 | 36000 USD | ? USD |
2023Q2 | -2.2 million USD | ? USD |
2023Q1 | -2.2 million USD | ? USD |
2022Q4 | -3.1 million USD | 86000 USD |
2022Q3 | -2.1 million USD | ? USD |
2022Q2 | -1.8 million USD | ? USD |
2022Q1 | -1.7 million USD | ? USD |
2021Q4 | -1.7 million USD | ? USD |
2021Q3 | -1.8 million USD | ? USD |
2021Q2 | -1.7 million USD | ? USD |
2021Q1 | -2.0 million USD | ? USD |
2020Q4 | -1.0 million USD | ? USD |
2020Q3 | -1.1 million USD | ? USD |
2020Q2 | -667000 USD | ? USD |
2020Q1 | -1.3 million USD | ? USD |
2019Q2 | -455000 USD | ? USD |
2019Q1 | -455000 USD | ? USD |
2018Q4 | -319750 USD | ? USD |
2018Q2 | -208000 USD | ? USD |
2018Q1 | -208000 USD | ? USD |
2017Q4 | -207000 USD | ? USD |
PRFX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -9.3 million USD | ? USD |
2022 | -8.8 million USD | 86000 USD |
2021 | -7.2 million USD | ? USD |
2020 | -4.1 million USD | ? USD |
2019 | -1.8 million USD | ? USD |
2018 | -828000 USD | ? USD |
2017 | -1.1 million USD | ? USD |
PRFX
Price: $0.82
52 week price:
Earnings Per Share: -7.14 USD
P/E Ratio: -0.30
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 9700
Market Capitalization: 2.9 million